- Home
- ARCT vs QTRX Comparison
ARCT vs QTRX Comparison
Compare ARCT & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- QTRX
- Stock Information
- Founded
- ARCT 2013
- QTRX 2007
- Country
- ARCT United States
- QTRX United States
- Employees
- ARCT N/A
- QTRX N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- ARCT Health Care
- QTRX Industrials
- Exchange
- ARCT Nasdaq
- QTRX Nasdaq
- Market Cap
- ARCT 320.8M
- QTRX 261.7M
- IPO Year
- ARCT N/A
- QTRX 2017
- Fundamental
- Price
- ARCT $19.48
- QTRX $4.57
- Analyst Decision
- ARCT Strong Buy
- QTRX Hold
- Analyst Count
- ARCT 8
- QTRX 4
- Target Price
- ARCT $48.83
- QTRX $11.75
- AVG Volume (30 Days)
- ARCT 648.4K
- QTRX 721.5K
- Earning Date
- ARCT 08-11-2025
- QTRX 08-07-2025
- Dividend Yield
- ARCT N/A
- QTRX N/A
- EPS Growth
- ARCT N/A
- QTRX N/A
- EPS
- ARCT N/A
- QTRX N/A
- Revenue
- ARCT $122,122,000.00
- QTRX $125,784,000.00
- Revenue This Year
- ARCT N/A
- QTRX N/A
- Revenue Next Year
- ARCT $37.73
- QTRX $14.40
- P/E Ratio
- ARCT N/A
- QTRX N/A
- Revenue Growth
- ARCT N/A
- QTRX N/A
- 52 Week Low
- ARCT $8.04
- QTRX $4.05
- 52 Week High
- ARCT $25.88
- QTRX $15.86
- Technical
- Relative Strength Index (RSI)
- ARCT 75.39
- QTRX 34.92
- Support Level
- ARCT $11.27
- QTRX $4.50
- Resistance Level
- ARCT $19.99
- QTRX $5.04
- Average True Range (ATR)
- ARCT 1.31
- QTRX 0.38
- MACD
- ARCT 0.79
- QTRX -0.13
- Stochastic Oscillator
- ARCT 94.15
- QTRX 17.44
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.